Table 7

 Pharmacological treatment of men and women with heart failure (HF) in Scotland, April 1999–March 2000

TreatmentAge group (years)
45–6465–7475–84>85<75⩾75All ages
Number1202483912403776311008
Furosemide66146238146216384600
(55.0%)(58.9%)(60.9%)(60.8%)(57.3%)(60.9%)(59.5%)
Any diuretic89200329190293519812
(74.2%)(80.7%)(84.1%)(79.2%)(77.7%)(82.3%)(80.6%)
ACE inhibitor6312414562188207395
(52.5%)(50.0%)(37.1%)(25.8%)(49.9%)(32.8%)(39.2%)
ARB910227192948
(7.5%)(4.0%)(5.6%)(2.9%)(5.0%)(4.6%)(4.8%)
β Blocker3461843696120216
(28.3%)(24.6%)(21.5%)(15.0%)(25.5%)(19.0%)(21.4%)
Spironolactone15262916414586
(12.5%)(10.5%)(7.4%)(6.9%)(10.9%)(7.1%)(8.5%)
Digoxin2348865072136208
(19.2%)(19.4%)(22.0%)(20.8%)(19.1%)(21.6%)(20.6%)
Any HF treatment106216355200328555883
(88.3%)(87.1%)(90.8%)(83.3%)(87.0%)(87.9%)(87.6%)